Buscar
Elanco Animal Health Inc
ELANAñadir a la lista de seguimiento
24.086USD
+0.126+0.53%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
11.97BCap. mercado
PérdidaP/E TTM
Más Datos de Elanco Animal Health Inc Compañía
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.
Información de Elanco Animal Health Inc
Símbolo de cotizaciónELAN
Nombre de la empresaElanco Animal Health Inc
Fecha de salida a bolsaSep 20, 2018
Director ejecutivoSimmons (Jeffrey N)
Número de empleados9000
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 20
Dirección450 Elanco Circle
CiudadINDIANAPOLIS
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal46221
Teléfono18773526261
Sitio Webhttps://www.elanco.com/
Símbolo de cotizaciónELAN
Fecha de salida a bolsaSep 20, 2018
Director ejecutivoSimmons (Jeffrey N)
Ejecutivos de Elanco Animal Health Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Mr. Paul S. Herendeen
Mr. Paul S. Herendeen
Independent Director
Independent Director
101.69K
+16.59%
Dr. Deborah Turner Kochevar, Ph.D.
Dr. Deborah Turner Kochevar, Ph.D.
Independent Director
Independent Director
94.39K
+4.96%
Ms. Shiv O'Neill
Ms. Shiv O'Neill
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
83.83K
+35.69%
Mr. James Meer
Mr. James Meer
Senior Vice President, Chief Accounting Officer
Senior Vice President, Chief Accounting Officer
71.18K
+12.12%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jeffrey N. (Jeff) Simmons
Mr. Jeffrey N. (Jeff) Simmons
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.25M
+27.46%
Mr. David Kinard
Mr. David Kinard
Executive Vice President - Human Resources, Corporate Communications and Administration
Executive Vice President - Human Resources, Corporate Communications and Administration
229.43K
+10.35%
Mr. Lawrence Erik Kurzius
Mr. Lawrence Erik Kurzius
Independent Chairman of the Board
Independent Chairman of the Board
187.21K
+9.01%
Mr. Timothy J. (Tim) Bettington
Mr. Timothy J. (Tim) Bettington
Executive Vice President - Corporate Strategy and Market Development
Executive Vice President - Corporate Strategy and Market Development
158.49K
+49.27%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
126.45K
+13.34%
Mr. Art A. Garcia, CPA
Mr. Art A. Garcia, CPA
Independent Director
Independent Director
108.15K
+15.60%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Elanco Animal Health Inc?
Los cinco principales accionistas de Elanco Animal Health Inc son: Mr. Jeffrey N. (Jeff) Simmons
¿Cuántas instituciones poseen acciones de Elanco Animal Health Inc (ELAN)?
A fecha de 2026Q1, 950 instituciones poseen acciones de Elanco Animal Health Inc, con un valor de mercado combinado de aproximadamente 549.30M, lo que representa el 109.98% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -60070109.00.
¿Cuál es la mayor fuente de ganancias de Elanco Animal Health Inc?
El 2026Q1, el segmento empresarial Farm Animal generó la ganancia más alta para Elanco Animal Health Inc, ascendiendo a 2.36B y representando el 50.10% de la ganancia total.
